A detailed history of Alyeska Investment Group, L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 2,000,000 shares of PFE stock, worth $53.4 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
2,000,000
Holding current value
$53.4 Million
% of portfolio
0.34%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $50.5 Million - $59.2 Million
2,000,000 New
2,000,000 $56 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $5.36 Million - $6.96 Million
205,104 New
205,104 $5.9 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $42.9 Million - $52 Million
-1,422,945 Reduced 65.04%
764,913 $23.7 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $59.1 Million - $84.5 Million
2,187,858 New
2,187,858 $67.8 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.